【深交所终止施美药业创业板IPO审核】财联社11月10日电,因江西施美药业股份有限公司、保荐人国金证券股份有限公司撤回发行上市申请,深交所决定终止其创业板发行上市审核。
“特别声明:以上作品内容(包括在内的视频、图片或音频)为凤凰网旗下自媒体平台“大风号”用户上传并发布,本平台仅提供信息存储空间服务。
Notice: The content above (including the videos, pictures and audios if any) is uploaded and posted by the user of Dafeng Hao, which is a social media platform and merely provides information storage space services.”